Literature DB >> 3994372

beta-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats.

D Gadelle, P Raibaud, E Sacquet.   

Abstract

The beta-glucuronidase activities of bacterial strains isolated from the rat intestinal tract were studied both in vitro in culture media and in vivo in the intestinal contents of gnotobiotic rats. Only 50 of 407 strains tested were found to be positive in vitro. They belonged to the three genera Clostridium, Peptostreptococcus, and Staphylococcus. The in vitro-negative strains were also negative in vivo. The beta-glucuronidase activities of the beta-glucuronidase activities of the positive strains were generally greater in vivo than in vitro. The highest in vivo activities were found in the intact bacterial cells and in the soluble fractions prepared from disrupted pellets. There was a discrepancy between the activities obtained from both conventional and gnotobiotic rats harboring selected positive strains, suggesting that the main beta-glucuronidase-positive strains have not yet been isolated from the intestines of conventional rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994372      PMCID: PMC373571          DOI: 10.1128/aem.49.3.682-685.1985

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  15 in total

1.  Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial beta-glucuronidase activity in F344 rats.

Authors:  B S Reddy; S Mangat; J H Weisburger; E L Wynder
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

2.  Origin of intestinal beta-glucuronidase in germfree, monocontaminated and conventional rats.

Authors:  T O Rod; T Midtvedt
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-08

3.  Glucuronidase activity in intestinal contents of rat and man and relationship to bacterial flora.

Authors:  T H Kent; L J Fischer; R Marr
Journal:  Proc Soc Exp Biol Med       Date:  1972-06

4.  Fecal bacterial beta-glucuronidase: control by diet.

Authors:  B S Reddy; J H Weisburger; E L Wynder
Journal:  Science       Date:  1974-02-01       Impact factor: 47.728

5.  Participation of liver fractions and of intestinal bacteria in the metabolism of N-hydroxy-N-2-fluorenylacetamide in the rat.

Authors:  J R Williams; P H Grantham; H H Marsh; J H Weisburger; E K Weisburger
Journal:  Biochem Pharmacol       Date:  1970-01       Impact factor: 5.858

6.  Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure.

Authors:  A Arank; S A Syed; E B Kenney; R Freter
Journal:  Appl Microbiol       Date:  1969-04

7.  [Microflora of the digestive system of the rat. I. Technics of study and proposed culture media].

Authors:  P Raibaud; A B Dickinson; E Sacquet; H Charlier; G Mocquot
Journal:  Ann Inst Pasteur (Paris)       Date:  1966-04

8.  Intestinal bacteria and the hydrolysis of glycosidic bonds.

Authors:  G Hawksworth; B S Drasar; M J Hill
Journal:  J Med Microbiol       Date:  1971-11       Impact factor: 2.472

9.  The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer.

Authors:  B R Goldin; S L Gorbach
Journal:  J Natl Cancer Inst       Date:  1976-08       Impact factor: 13.506

10.  Agar medium for the selective enumeration of coagulase-positive Staphylococcus from the rat alimentary tract.

Authors:  A B Dickinson; P Raibaud; G Mocquot
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

View more
  19 in total

1.  The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse.

Authors:  Carol J Díaz-Díaz; Sean M Ronnekleiv-Kelly; Manabu Nukaya; Peter G Geiger; Silvia Balbo; Romel Dator; Bryant W Megna; Patrick R Carney; Christopher A Bradfield; Gregory D Kennedy
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

Review 2.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.

Authors:  Bryan B Yoo; Sarkis K Mazmanian
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

3.  Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Authors:  B R Goldin; S L Gorbach; M Saxelin; S Barakat; L Gualtieri; S Salminen
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

Review 4.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 5.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 6.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

Review 7.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

Authors:  John L Wallace
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

8.  The metabolism of drugs by the gut flora.

Authors:  M Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

9.  Phenotypic and Phylogenetic Identification of Coliform Bacteria Obtained Using 12 Coliform Methods Approved by the U.S. Environmental Protection Agency.

Authors:  Ya Zhang; Pei-Ying Hong; Mark W LeChevallier; Wen-Tso Liu
Journal:  Appl Environ Microbiol       Date:  2015-06-26       Impact factor: 4.792

10.  Establishment of Lactobacillus and Bifidobacterium species in germfree mice and their influence on some microflora-associated characteristics.

Authors:  K E Norin; A K Persson; H Saxerholt; T Midtvedt
Journal:  Appl Environ Microbiol       Date:  1991-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.